Dexcom Fights Abbott's Bid to Invalidate Glucose Monitors
Dexcom has urged a London court to invalidate several glucose monitoring patents held by of Abbott Laboratories, hitting back at allegations that its systems infringe on the rival's protected technology....To view the full article, register now.
Already a subscriber? Click here to view full article